Prenatal endocrine activation alters postnatal cellular immunity in infant monkeys

Brain, Behavior, and Immunity
Christopher L CoeW B Ershler

Abstract

Cellular immune responses were evaluated in 35 infant rhesus monkeys generated from two types of pregnancy conditions. Pregnant females were administered either saline or adrenocorticotropic hormone (ACTH) for 2 weeks between Days 120 and 133 postconception, approximately 1 month before parturition. After birth, lymphocytes obtained from infants in the ACTH condition failed to respond as readily to allogeneic cells in mixed lymphocyte cultures, proliferated less to Con A, exhibited lower suppressor function following stimulation with Con A, and showed lower cytolytic activity against target cells. For some measures, the prenatal effect was observed more consistently in male infants. Differences were evident with these in vitro immune assays through 6 months of age, indicating that acute disturbance during the prenatal period can have lingering effects on postnatal immunity.

Citations

Aug 7, 2013·Animal : an International Journal of Animal Bioscience·E MerlotA Prunier
Aug 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sonja EntringerPathik D Wadhwa
Jan 31, 2002·American Journal of Respiratory and Critical Care Medicine·Rosalind J WrightDiane R Gold
Jun 7, 2005·American Journal of Veterinary Research·Godelieve KranendonkMarcel Taverne
Feb 15, 2012·Advances in Nutrition·Amanda C Palmer
Aug 2, 2014·Journal of Developmental Origins of Health and Disease·E C BraithwaiteP G Ramchandani
Feb 1, 2014·Evolution, Medicine, and Public Health·Graham A W RookCharles L Raison
Jun 17, 2010·Brain Research Reviews·Arnaud CharilSuzanne King
Apr 14, 2009·Veterinary Immunology and Immunopathology·David CouretElodie Merlot
Jan 20, 2009·Brain, Behavior, and Immunity·Eugen MattesSusan L Prescott
Dec 17, 2008·Hormones and Behavior·Sonja EntringerStefan Wüst
Apr 1, 2008·Lancet·John P Capitanio, Marina E Emborg
Aug 25, 2007·Brain, Behavior, and Immunity·E MerlotW Otten
Sep 10, 2004·The European Journal of Neuroscience·Giovanni LaviolaRoberta Pacifici
Aug 18, 2005·American Journal of Reproductive Immunology : AJRI·Maike Katharina KnackstedtPetra Clara Arck
Nov 20, 2008·Journal of Child Psychology and Psychiatry, and Allied Disciplines·K BergmanT G O'Connor
Jan 18, 2005·Neuroscience and Biobehavioral Reviews·Christopher L Coe, Gabriele R Lubach
Mar 2, 2010·Biological Psychiatry·Kristin BergmanThomas G O'Connor
Nov 20, 2003·Biological Psychiatry·Christopher L CoeEberhard Fuchs
Apr 16, 2004·Journal of Pediatric Gastroenterology and Nutrition·Michael T BaileyChristopher L Coe
Oct 8, 2005·Neuroendocrinology·Evelise S M FonsecaJoão Palermo Neto
May 1, 2009·Journal of Immunotoxicology·Denise L BellingerDianne Lorton
Nov 18, 2005·ANS. Advances in Nursing Science·R Jeanne Ruiz, Kay C Avant
Feb 12, 2002·The Journal of Clinical Endocrinology and Metabolism·Christopher L CoeEberhard Fuchs
Aug 4, 1998·The American Journal of Physiology·T M Reyes, C L Coe
Mar 28, 2001·Annals of the New York Academy of Sciences·C L Coe, G R Lubach
Sep 22, 2001·The American Journal of Clinical Nutrition·T W McDadeL S Adair
Jan 15, 2014·Expert Review of Respiratory Medicine·Peter A B WarkJoerg Mattes
Apr 1, 2011·Stress and Health : Journal of the International Society for the Investigation of Stress·Nora MayerHector Gauna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.